Back to search results

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

Abroad (travel likely)RecruitingPHASE3

Conditions

Growth Hormone Deficiency (GHD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Lumos Pharma Investigational Site, Birmingham, Alabama, United States

  • Lumos Pharma Investigational Site, Madera, California, United States

  • Lumos Pharma Investigational Site, Orange, California, United States

  • Lumos Pharma Investigational Site, Sacramento, California, United States

  • Lumos Pharma Investigational Site, San Diego, California, United States

  • Lumos Pharma Investigational Site, Centennial, Colorado, United States

  • Lumos Pharma Investigational Site, Greenwood Village, Colorado, United States

  • Lumos Pharma Investigational Site, Washington D.C., District of Columbia, United States

  • Lumos Pharma Investigational Site, Hollywood, Florida, United States

  • Lumos Pharma Investigational Site, Miami, Florida, United States

  • Lumos Pharma Investigational Site, Orlando, Florida, United States

  • Lumos Pharma Investigational Site, Tallahassee, Florida, United States

  • Lumos Pharma Investigational Site, Indianapolis, Indiana, United States

  • Lumos Pharma Investigational Site, Iowa City, Iowa, United States

  • Lumos Pharma Investigational Site, New Orleans, Louisiana, United States

  • Lumos Pharma Investigational Site, Minneapolis, Minnesota, United States

  • Lumos Pharma Investigational Site, Kansas City, Missouri, United States

  • Lumos Pharma Investigational Site, Las Vegas, Nevada, United States

  • Lumos Pharma Investigational Site, New Brunswick, New Jersey, United States

  • Lumos Pharma Investigational Site, Staten Island, New York, United States

  • Lumos Pharma Investigational Site, Oklahoma City, Oklahoma, United States

  • Lumos Pharma Investigational Site, Columbia, South Carolina, United States

  • Lumos Pharma Investigational Site, Amarillo, Texas, United States

  • Lumos Pharma Investigational Site, Corpus Christi, Texas, United States

  • Lumos Pharma Investigational Site, Fort Worth, Texas, United States

  • Lumos Pharma Investigational Site, San Antonio, Texas, United States

  • Lumos Pharma Investigational Site, Charlottesville, Virginia, United States

  • Lumos Pharma Investigational Site, Seattle, Washington, United States

  • Lumos Pharma Investigational Site, South Brisbane, Queensland, Australia

  • Lumos Pharma Investigational Site, Clayton, Victoria, Australia

  • Lumos Pharma Investigational Site, Parkville, Victoria, Australia

  • Lumos Pharma Investigational Site, Auckland, New Zealand

  • Lumos Pharma Investigational Site, Wellington, New Zealand

  • Lumos Pharma Investigational Site, Bangkok Noi, Bangkok, Thailand

  • Lumos Pharma Investigational Site, Pathumwan, Bangkok, Thailand

  • Lumos Pharma Investigational Site, Muang, Changwat Khon Kaen, Thailand

  • Lumos Pharma Investigational Site, Hat Yai, Changwat Songkhla, Thailand

  • Lumos Pharma Investigational Site, Muang, Chiang Mai, Thailand

  • Lumos Pharma Investigational Site, Liverpool, England, United Kingdom

  • Lumos Pharma Investigational Site, London, England, United Kingdom

  • Lumos Pharma Investigational Site, London, England, United Kingdom

  • Lumos Pharma Investigational Site, Sheffield, England, United Kingdom

View source on ClinicalTrials.gov(opens in a new tab)